Organisation paid for research Program year 2025 Source: CMS Open Payments

Planned Parenthood North Central States

Neither a doctor nor a teaching hospital

Research payments

$1,994,032

134 payments

Through program year 2025, Planned Parenthood North Central States is reported as receiving $1,994,032 in research payments, across 134 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$765,987	68
2024	Research	$166,312	26
2023	Research	$729,602	33
2022	Research	$314,647	5
2021	Research	$17,485	2

Breakdown

Who paid Research payments · program years 2021–2025

Roche Molecular Systems, Inc. $963,711 72 payments
Visby Medical, Inc. $624,828 27 payments
Beckman Coulter, Inc. $265,198 2 payments
Mylan Inc. $85,792 29 payments
OraSure Technologies Inc. $37,019 2 payments
Cepheid $17,485 2 payments

Studies the money was for Research payments · program years 2021–2025

Rd005944 $442,318 23 payments
Rd007113 $427,719 39 payments
Blood Virus (HIV-01-18, HBV-01-18, HCV-01-18) $161,588 1 payment
A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV (Clinical Protocol No. TP-000377) / A Beta Study of the Visby Sexual Health Test (Clinical Protocol No. TP-000516) / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000558) $153,059 4 payments
A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV / A Beta Study of the Visby Sexual Health Test / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test $129,930 4 payments
Reproducibility Study for the Visby Medical Men's Sexual Health Test $118,311 7 payments
Clinical Evaluation of Visby Medical Men's Sexual Health Test $118,311 7 payments
Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs $105,218 5 payments
HBV/HCV/HIV enrollment $103,610 1 payment
Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $85,792 29 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.